Galectin

亜型選択性的な製品

Galectin製品

  • All (6)
  • Galectin阻害剤 (3)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S0471 Olitigaltin (TD-139) Olitigaltin (TD-139, GB0-139) is a potent and selective inhibitor of galectin-3 with Kd of 0.036 µM over galectin-1 and galectin-7 with Kd of 2.2 µM and 32 µM, respectively. TD-139 is used potentially for the treatment of idiopathic pulmonary fibrosis (IPF).
Nat Commun, 2025, 16(1):2419
Biomaterials, 2025, 315:122922
J Mater Chem B, 2025, 13(10):3325-3339
S6949 OTX008 OTX008 (Calixarene 0118, PTX008), a calixarene derivative, is a selective inhibitor of galectin-1 (Gal1) with anti-tumoural activity.
Biochem Pharmacol, 2024, 229:116474
Pharmaceuticals (Basel), 2024, 17(1)107
Front Pharmacol, 2023, 14:1332212
F1417 Galectin-3/LGALS3 Antibody [N13N19]
F1039 Galectin 1 Antibody [H13A2] Galectin 1 Rabbit mAb recognizes endogenous levels of total Galectin 1 protein.
Cell Death Dis, 2024, 15(7):482
F1286 Galectin-9 Antibody [J3M6] Galectin-9 Rabbit mAb recognizes endogenous levels of total galectin-9 protein.
S8834 GB1107 GB1107 is a potent, selective, inhibitor of Galectin-3 (Gal-3) with a Kd of 37 nM for human Galectin-3.
BMC Musculoskelet Disord, 2024, 25(1):249
S0471 Olitigaltin (TD-139) Olitigaltin (TD-139, GB0-139) is a potent and selective inhibitor of galectin-3 with Kd of 0.036 µM over galectin-1 and galectin-7 with Kd of 2.2 µM and 32 µM, respectively. TD-139 is used potentially for the treatment of idiopathic pulmonary fibrosis (IPF).
Nat Commun, 2025, 16(1):2419
Biomaterials, 2025, 315:122922
J Mater Chem B, 2025, 13(10):3325-3339
S6949 OTX008 OTX008 (Calixarene 0118, PTX008), a calixarene derivative, is a selective inhibitor of galectin-1 (Gal1) with anti-tumoural activity.
Biochem Pharmacol, 2024, 229:116474
Pharmaceuticals (Basel), 2024, 17(1)107
Front Pharmacol, 2023, 14:1332212
S8834 GB1107 GB1107 is a potent, selective, inhibitor of Galectin-3 (Gal-3) with a Kd of 37 nM for human Galectin-3.
BMC Musculoskelet Disord, 2024, 25(1):249